A fluorescent hPept1 transporter substrate for uptake screening

被引:12
作者
Landowski, CP [1 ]
Han, HK [1 ]
Lee, KD [1 ]
Amidon, GL [1 ]
机构
[1] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA
关键词
fluorescent substrate; oligopeptide transporter; hPept1; HeLa; Caco-2; permeability;
D O I
10.1023/B:PHAM.0000003369.64891.51
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To synthesize fluorescent analogues of hPept1 substrates, FITC-Val-OCH3, Lys-FITC-OH, and Lys-FITC-OCH3, and to characterize their hPept1 transporter-mediated uptake. Methods. FITC analogues of amino acids were synthesized using established synthetic procedures, and the extent of their [H-3] Gly-Sar uptake inhibition in HeLa/hPept1 cells was determined. The uptake of Lys-FITC-OCH3 was evaluated in HeLa, HeLa/hPept1, and Caco- 2 cells in the presence and absence of Gly-Sar using a fluorescence microscopy- based assay. The uptake and transport of the Lys-FITC analogues were also determined in Caco- 2 cells using HPLC assays. Results. In HeLa/hPept1 cells, [H-3] Gly-Sar uptake was significantly inhibited by Lys-FITC-OCH3 (74%) but not by FITC-Val-OCH3 (22%). The uptake of Lys-FITC-OCH3 (100 muM) was approximately 10-fold higher in HeLa/hPept1 cells. Also, Lys-FITC-OCH3 (100 muM) uptake in HeLa/ hPept1 and Caco- 2 cells was reduced by 77% and 80%, respectively, in the presence of 1 mM Gly- Sar. Dipeptides and cephalexin significantly reduced Lys-FITC-OCH3 uptake in Caco- 2 cells. The apical permeability of Lys-FITC-OCH3 (1.5 x 10(6) cm/s) in Caco- 2 cells was significantly lowered in the presence of Gly- Sar. Fluorescence micrographs revealed that this analogue was localized in the cytoplasm and in the nucleus. Conclusions. The combined results indicate that Lys-FITC-OCH3 is recognized and transported by hPept1 in HeLa/ hPept1 and by peptide transporters in Caco- 2 cells. The results also suggest that Lys-FITC-OCH3 might be a useful fluorescent substrate for rapid assessment of peptide transporter activity in cells of interest.
引用
收藏
页码:1738 / 1745
页数:8
相关论文
共 17 条
[1]   Conjugation of dipeptide to fluorescent dyes enhances its affinity for a dipeptide transporter (PEPT1) in human intestinal Caco-2 cells [J].
Abe, H ;
Satoh, M ;
Miyauchi, S ;
Shuto, S ;
Matsuda, A ;
Kamo, N .
BIOCONJUGATE CHEMISTRY, 1999, 10 (01) :24-31
[2]   PHARMACOKINETICS OF ACYCLOVIR AFTER INTRAVENOUS AND ORAL-ADMINISTRATION [J].
DEMIRANDA, P ;
BLUM, MR .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 12 :29-37
[3]  
Gonzalez DE, 1998, CANCER RES, V58, P519
[4]   Intestinal peptide transport:: ex vivo uptake studies and localization of peptide carrier PEPT1 [J].
Groneberg, DA ;
Döring, F ;
Eynott, PR ;
Fischer, A ;
Daniel, H .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2001, 281 (03) :G697-G704
[5]   Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter [J].
Han, HK ;
Oh, DM ;
Amidon, GL .
PHARMACEUTICAL RESEARCH, 1998, 15 (09) :1382-1386
[6]   5′-amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter [J].
Han, HK ;
de Vrueh, RLA ;
Rhie, JK ;
Covitz, KMY ;
Smith, PL ;
Lee, CP ;
Oh, DM ;
Sadee, W ;
Amidon, GL .
PHARMACEUTICAL RESEARCH, 1998, 15 (08) :1154-1159
[7]   Overexpression of human intestinal oligopeptide transporter in mammalian cells via adenoviral transduction [J].
Hsu, CP ;
Hilfinger, JM ;
Walter, E ;
Merkle, HP ;
Roessler, BJ ;
Amidon, GL .
PHARMACEUTICAL RESEARCH, 1998, 15 (09) :1376-1381
[8]   PASSIVE AND CARRIER-MEDIATED INTESTINAL-ABSORPTION COMPONENTS OF CAPTOPRIL [J].
HU, M ;
AMIDON, GL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (12) :1007-1011
[9]  
INUI KI, 1992, J PHARMACOL EXP THER, V260, P482
[10]   HUMAN PHARMACOKINETICS AND TOLERANCE OF ORAL GANCICLOVIR [J].
JACOBSON, MA ;
DEMIRANDA, P ;
CEDERBERG, DM ;
BURNETTE, T ;
COBB, E ;
BRODIE, HR ;
MILLS, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (08) :1251-1254